1. Home
  2. PRE vs HURA Comparison

PRE vs HURA Comparison

Compare PRE & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRE
  • HURA
  • Stock Information
  • Founded
  • PRE 2014
  • HURA 2009
  • Country
  • PRE Hong Kong
  • HURA United States
  • Employees
  • PRE N/A
  • HURA N/A
  • Industry
  • PRE Biotechnology: Laboratory Analytical Instruments
  • HURA
  • Sector
  • PRE Industrials
  • HURA
  • Exchange
  • PRE Nasdaq
  • HURA Nasdaq
  • Market Cap
  • PRE 131.3M
  • HURA 131.8M
  • IPO Year
  • PRE N/A
  • HURA N/A
  • Fundamental
  • Price
  • PRE $15.87
  • HURA $2.40
  • Analyst Decision
  • PRE Buy
  • HURA Strong Buy
  • Analyst Count
  • PRE 1
  • HURA 2
  • Target Price
  • PRE $9.00
  • HURA $11.50
  • AVG Volume (30 Days)
  • PRE 149.0K
  • HURA 189.4K
  • Earning Date
  • PRE 11-26-2025
  • HURA 11-13-2025
  • Dividend Yield
  • PRE N/A
  • HURA N/A
  • EPS Growth
  • PRE N/A
  • HURA N/A
  • EPS
  • PRE N/A
  • HURA N/A
  • Revenue
  • PRE $57,051,000.00
  • HURA N/A
  • Revenue This Year
  • PRE $202.46
  • HURA N/A
  • Revenue Next Year
  • PRE $103.60
  • HURA N/A
  • P/E Ratio
  • PRE N/A
  • HURA N/A
  • Revenue Growth
  • PRE 151.74
  • HURA N/A
  • 52 Week Low
  • PRE $3.10
  • HURA $1.80
  • 52 Week High
  • PRE $16.98
  • HURA $8.34
  • Technical
  • Relative Strength Index (RSI)
  • PRE 69.77
  • HURA 42.83
  • Support Level
  • PRE $13.07
  • HURA $2.37
  • Resistance Level
  • PRE $14.89
  • HURA $2.61
  • Average True Range (ATR)
  • PRE 1.18
  • HURA 0.14
  • MACD
  • PRE -0.05
  • HURA 0.00
  • Stochastic Oscillator
  • PRE 75.68
  • HURA 10.34

About PRE Prenetics Global Limited

Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.

About HURA TuHURA Biosciences Inc. Common Stock

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.

Share on Social Networks: